References
- 1. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. Journal of bone and mineral research. 1994; 9(8):1137-1141.
- 2. Riggs BL, Melton Iii LJ. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995; 17(5):S505-S511.10.1016/8756-3282(95)00258-4
- 3. Rosen CJ, Compston JE, Lian JB. ASBMR primer on the metabolic bone diseases and disorders of mineral metabolism. 2009, John Wiley & Sons.
- 4. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Stracke H. Risk of new vertebral fracture in the year following a fracture. Jama. 2001; 285(3):320-323.
- 5. Cooper C. The crippling consequences of fractures and their impact on quality of life. The American Journal of Medicine. 1997; 103(2):S12-S19.
- 6. Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures. Osteoporosis International. 2000; 11(7):556-561.10.1007/s001980070075
- 7. Sinescu RD, Niculae A, Peride I, Vasilescu F, Bratu OG, Mischianu DL, Checheriţă IA. Uterus neuroendocrine tumor–a severe prognostic factor in a female patient with alcoholic cirrhosis undergoing chronic hemodialysis. Rom J Morphol Embryol. 2015; 56(2):601-605.
- 8. Bratu O, Mischianu D, Spanu D, Barla R, Hoara P, Constantinoiu S. Paraneoplastic Syndrome in Primitive Retroperitoneal Tumours. Chirurgia. 2013; 108:26-31.
- 9. Niculae A, Peride I, Vinereanu V, Radulescu D, Bratu OG, Geavlete BF, Checherita IA. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS). Rom J Morphol Embryol. 2017; 58(3):1065-1068.
- 10. Niculae A, Peride I, Marinescu-Paninopol A, Vrabie CD, Ginghina O, Jecan CR, Bratu OG. Renal artery bilateral arteriosclerosis cause of resistant hypertension in hemodialysed patients. Rom J Morphol Embryol. 2016; 57(2):591-594.
- 11. Checherita IA, Smarandache D, Radulesc D, Peride I, Bratu O, Ciocâlteu A, Lascar I. Calcific uremic arteriolopathy in hemodialyzed patients. Chirurgia. 2013; 108(5):736-740.
- 12. Radulescu D, Stroescu A, Pricop C, Geavlete B, Negrei C, Bratu O, Vacaroiu IA. Vitamin K Influence on Cardiovascular Mortality in Chronic Hemodialysed Patients. Revista de Chimie. 2017; 68(1):52-54.
- 13. Kling JM, Clarke BL, Sandhu NP. Osteoporosis prevention, screening, and treatment: a review. Journal of Women's Health. 2014; 23(7):563-572.
- 14. Warriner AH, Saag KG. Osteoporosis diagnosis and medical treatment. Orthopedic Clinics. 2013; 44(2):125-135.
- 15. Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, Ichimura S. Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004). Journal of Bone and Mineral Metabolism. 2005; 23(2):97-104.
- 16. Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O, Borgström F. Development and use of FRAX® in osteoporosis. Osteoporosis International. 2010; 21(2):407-413.10.1007/s00198-010-1253-y
- 17. Daroszewska A. Prevention and treatment of osteoporosis in women: an update. Obstetrics, Gynaecology & Reproductive Medicine. 2012; 22(6):162-169.
- 18. Li K, Kaaks R, Linseisen J, Rohrmann S. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart. 2012; 98(12):920-925.10.1136/heartjnl-2011-301345
- 19. Stevenson M, Jones ML, De Nigris E, Brewer N, Davis S, Oakley J. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. 2005.
- 20. Baim S, Miller PD. Perspective: assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. Journal of Bone and Mineral Research. 2009; 24(4):561-574.10.1359/jbmr.090203
- 21. Woo SB, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Annals of Internal Medicine. 2006; 144(10):753-761.
- 22. Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Laupacis A. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. Jama. 2011; 305(8):783-789.
- 23. Grimer RJ. Denosumab: a drug that you may be hearing a lot more about. Bone&Joint 360. 2013; 2(5):43-44.